| Structure | Chemical Name | CAS | MF |
|
GNE-9815
|
2729996-45-4
|
C26H22FN5O2
|
|
(4S,12aS)-7-Methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic Acid
|
2730133-58-9
|
C14H16N2O6
|
|
Trimetazidine n-Oxide Dihydrochloride
|
2731228-51-4
|
C14H23ClN2O4
|
|
DOXYLAMINE HYDROGEN SUCCINATE
|
2731375-61-2
|
C20H26N2O5
|
|
Benzamide, 5-[2,2-dimethyl-3-(1-methyl-3-phenylpropyl)-5-oxazolidinyl]-2-hydroxy-
|
2731858-23-2
|
C22H28N2O3
|
|
Labetalol iMpurity
|
2731858-23-2
|
|
|
Cetirizine ethyl ester dihydrochloride
|
2732277-01-7
|
C23H30Cl2N2O3
|
|
2-methoxy-9,9-diphenyl-fluorene
|
2732789-36-3
|
C26H20O
|
|
BAY 2965501
|
2732902-08-6
|
C20H19FN4O3S
|
|
Glycine, N-methyl-, [2-(methylamino)-3-pyridinyl]methyl ester
|
2732924-98-8
|
C10H15N3O2
|
|
Isavuconazole Impurity 11
|
2732924-99-9
|
C10H16ClN3O2
|
|
N-Desethyl Isotonitazene
|
2732926-24-6
|
C21H26N4O3
|
|
N-desethyl Etonitazene
|
2732926-26-8
|
C20H24N4O3
|
|
Cinoxacin-D5
|
2732985-25-8
|
C12H10N2O5
|
|
Bosutinib-d8
|
2733145-45-2
|
C26H29Cl2N5O3
|
|
tert-butyl N-(5-oxo-4,5-dihydropyrazin-2-yl)carbamate
|
2733641-59-1
|
C9H13N3O3
|
|
Glycine, N-methyl-, [2-[[(ethenyloxy)carbonyl]methylamino]-3-pyridinyl]methyl ester
|
2733698-17-2
|
C13H17N3O4
|
|
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-, 3-ethyl 5-methyl ester, compd. with benzenesulfonate (1:1)
|
2733700-89-3
|
C20H23ClN2O5.C6H6O3S
|
|
2H-Pyrido[2,3-d][1,3]oxazin-2-one, 1,4-dihydro-1-methyl-
|
2734004-61-4
|
C8H8N2O2
|
|
Metaraminol Bitartrate Impurity 5
|
2734404-77-2
|
C16H15NO3
|
|
N-acetyl W-19
|
2734475-96-6
|
C21H24ClN3O3S
|
|
1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1,4-dioxido-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, methyl ester
|
2734676-68-5
|
C31H33N5O6
|
|
L-Glutamic acid, N-[4-[(2-amino-3,4-dihydro-7-methyl-4-oxo-6-pteridinyl)amino]benzoyl]-
|
2734707-85-6
|
C19H19N7O6
|
|
1-Pentanol, 5-amino-4-methyl-, hydrochloride (1:1), (4R)-
|
2734714-91-9
|
C6H16ClNO
|
|
2-Pyrazinecarboxylic acid, 5-methyl-, 1,4-dioxide
|
2734844-49-4
|
C6H6N2O4
|
|
Adenosine, 5′-chloro-5′-deoxy-2-fluoro-
|
2734853-80-4
|
C10H11ClFN5O3
|
|
4',4''',4''''',4'''''''-(pyrene-1,3,6,8-tetrayl)tetrakis(([1,1'-biphenyl]-4-carbaldehyde))
|
2734880-96-5
|
C68H42O4
|
|
c-di-AMP disodium
|
2734909-87-4
|
C20H25N10NaO12P2
|
|
Gly-Gly-Gly-Lys(N3)
|
2737202-70-7
|
C12H21N7O5.ClH
|
|
Butane, 2,2,3,3-tetrafluoro-1,4-dimethoxy-
|
2738080-99-2
|
C6H10F4O2
|
|
Pentanedioic acid, 3-[[[(1S,5R,6R)-6-(acetylamino)-3-(ethoxycarbonyl)-5-(1-ethylpropoxy)-3-cyclohexen-1-yl]amino]carbonyl]-3-hydroxy-
|
2738248-87-6
|
C22H34N2O10
|
|
3-Pyridinecarboxylic acid, 4-amino-2,6-dichloro-, 2,2,2-trifluoroacetate (1:1)
|
2738350-84-8
|
C8H5Cl2F3N2O4
|
|
Orlistat-d3
|
2738374-25-7
|
C29H53NO5
|
|
Cilastatin-15N-d3
|
2738376-83-3
|
C16H23D3N2O5S
|
|
2,2'-(propane-2,2-diyl)bis(5-(tert-butyl)benzo[d]oxazole)
|
2738657-17-3
|
C25H30N2O2
|
|
2,2'-(propane-2,2-diyl)bis(5-fluorobenzo[d]oxazole)
|
2738657-27-5
|
C17H12F2N2O2
|
|
3-Pyridazinecarboxylic acid, hexahydro-, hydrochloride (1:2)
|
2738899-29-9
|
C5H11ClN2O2
|
|
NT1-O14B
|
2739805-64-0
|
C40H68N2O4S4
|
|
7H-8,12-Metheno-4H-pyrazolo[3,4-h]-1,2,3-triazolo[4,5-k][2,5]benzoxaazacyclotetradecin-11-amine, 7-ethyl-16-fluoro-2,14-dihydro-2,14-dimethyl-, (14R)-
|
2739829-00-4
|
C22H22FN7O
|
|
Boronic acid, B-(3-cyano-1-methyl-1H-pyrazol-5-yl)-
|
2739830-29-4
|
C5H6BN3O2
|
|
1H-Pyrazole, 3-chloro-1-ethyl-4-iodo-
|
2739835-90-4
|
C5H6ClIN2
|
|
5-Pyrimidinecarboxamide, 4-[[2-(hydroxymethyl)phenyl]amino]-2-[(1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinyl)amino]-
|
2739844-28-9
|
C23H26N6O3
|
|
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, methyl ester, (αR,3R)-rel-
|
2740235-22-5
|
C13H22N2O5
|
|
[1,1′-Biphenyl]-4-amine, 4′,4′′′,4′′′′′,4′′′′′′′-methanetetrayltetrakis-
|
2740557-60-0
|
C49H40N4
|
|
[(2S)-oxetan-2-yl]methana mine-4-methylbenzenesul fonic acid
|
2740593-38-6
|
C11H17NO4S
|
|
D-Glutamic acid, 4-(cyanomethyl)-N-[(1,1-dimethylethoxy)carbonyl]-, 1,5-dimethyl ester, (4S)-rel-
|
2740644-40-8
|
C14H22N2O6
|
|
5-bromo-2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione
|
2740657-28-5
|
C13H8BrFN2O4
|
|
1H-Isoindole-1,3(2H)-dione, 4-bromo-2-(2,6-dioxo-3-piperidinyl)-7-fluoro-
|
2740657-30-9
|
C13H8BrFN2O4
|
|
2H-Indazole, 5-bromo-6-chloro-2-methyl-
|
2741600-25-7
|
C8H6BrClN2
|
|
Benzonitrile, 3-[(1S)-1-aminoethyl]-, hydrochloride (1:1)
|
2741870-03-9
|
C9H11ClN2
|
|
Difelikefalin impurity
|
2742623-84-1
|
C36H53N7O6
|
|
3-(Bromomethyl)bicyclo[1.1.1]pentane-1-carboxylic acid
|
2742661-04-5
|
C7H9BrO2
|
|
3-Azabicyclo[3.1.0]hexane-2-carboxylic acid, 3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, methyl ester, (1R,2S,5S)-
|
2742706-71-2
|
C17H25F3N2O4
|
|
3-Pyrrolidinepropanenitrile, α-amino-2-oxo-, (αS,3S)-
|
2742706-72-3
|
C7H11N3O
|
|
(R)-N-benzyl-3-methoxy-2-(N-methylacetamido)propanamide
|
2742962-60-1
|
C14H20N2O3
|
|
Hexacosanoic Acid Methyl Ester-d3
|
2743078-84-2
|
C27H51D3O2
|
|
GSK215
|
2743427-26-9
|
C50H59F3N10O6S
|
|
9-(2,5-DIMETHYLPHENYL)-10-METHYLACRIDINIUM PERCHLORATE
|
2743539-93-5
|
C22H20N.ClO4
|
|
2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(2-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-
|
2743547-96-6
|
C24H21F2NO3
|
|
Furan, 3-[2-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-, (3S)-
|
2744280-76-8
|
C17H16BrClO2
|
|
tert-butyl (2-(2-hydroxyethoxy)ethyl)(2-(methylamino)ethyl)carbamate
|
2745053-79-4
|
C12H26N2O4
|
|
Y6-OD-2Br
|
2747095-27-6
|
C106H136Br2N8O2S5
|
|
Y6-OD-2Br
|
2747095-28-7
|
C106H136Br2N8O2S5
|
|
ADBICA-d9
|
2747914-01-6
|
C20H20D9N3O2
|
|
|
CarbinoxaMine-d6 Maleate
|
2747914-08-3
|
|
|
Cefditoren Pivoxil-d3
|
2747915-67-7
|
C19H18N6O5S3
|
|
JWH 203 N-(4-hydroxypentyl) metabolite-d5
|
2747915-98-4
|
C21H17ClD5NO2
|
|
RCS-4 N-(4-hydroxypentyl) metabolite-d5
|
2747917-61-7
|
C21H18D5NO3
|
|
UR-144 N-(4-hydroxypentyl) metabolite-d5
|
2747917-78-6
|
C21H24D5NO2
|
|
|
Clevidipine-d7
|
2747918-66-5
|
|
|
Spiro[4H-3,1-benzoxazine-4,7'(6'H)-pyrrolo[1,2-a]pyrazine]-1',2,4'(1H)-trione, 6'-(1,3-benzodioxol-5-yl)-2',3',8',8'a-tetrahydro-2'-methyl-, (8'aR)-
|
2747958-44-5
|
C22H19N3O6
|
|
Phosphonic acid, P-[4-(3,6-dimethyl-9H-carbazol-9-yl)butyl]-
|
2747959-96-0
|
C18H22NO3P
|
|
4-Hydroxy Solifenacin N-Oxide
|
2747991-39-3
|
C23H26N2O4
|
|
9-PAHSA-d31
|
2748208-06-0
|
C34H35D31O4
|
|
JWH 250 N-(5-hydroxypentyl) metabolite-d5
|
2748212-89-5
|
C22H20D5NO3
|
|
MAM2201 N-(5-chloropentyl) analog-d5
|
2748212-99-7
|
C25H19ClD5NO
|
|
OMEPRAZOLE IMP. F (EP): 2,12-DIHYDRO-1,3-DIMETHYL-8-METHOXY-12-THIOXOBENZO[4,5]PYRIDO[1,2-C]IMIDAZO[1,2-A]IMIDAZOL-2-ONE MM STANDARD
|
2748245-58-9
|
C16H15N3O2S
|
|
EthionaMide-d3
|
2748267-66-3
|
C8H7D3N2S
|
|
Benzenemethanol, 2-chloro-α-[[[1-(methyl-d3)ethyl-1,2,2,2-d4]amino]methyl]-, (αR)-
|
2748354-86-9
|
C11H9ClD7NO
|
|
LORATADINE-D4
|
2748435-73-4
|
C22H19ClD4N2O2
|
|
JWH 073 2-hydroxyindole metabolite-d7
|
2748464-25-5
|
C23H14D7NO2
|
|
JWH 398 N-(5-hydroxypentyl) metabolite-d5
|
2748469-33-0
|
C24H17ClD5NO2
|
|
JWH 018 5-hydroxyindole metabolite-d9
|
2748533-34-6
|
C24H14D9NO2
|
|
(S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite
|
2748589-83-3
|
C23H21NO2
|
|
2C-B-BZP (hydrochloride)
|
2748622-68-4
|
C13H21BrCl2N2O2
|
|
JWH 307 3'-isomer
|
2748622-89-9
|
C26H24FNO
|
|
9-PAHSA 13C4
|
2748638-71-1
|
C34H66O4
|
|
Dantrolene-d4
|
2749234-17-9
|
C14H6D4N4O5
|
|
Alogliptin Imp.12
|
2749281-73-8
|
C25H25N5O3
|
|
AM2201 5-hydroxyindole metabolite
|
2749282-57-1
|
C24H22FNO2
|
|
12-PAHSA-d31
|
2749293-89-6
|
C34H35D31O4
|
|
Haloperidol Decanoate N-Oxide
|
2749298-36-8
|
C31H41ClFNO4
|
|
4-MA-NBOMe (hydrochloride)
|
2749298-47-1
|
C18H24ClNO
|
|
JWH 073 7-hydroxyindole metabolite-d7
|
2749316-88-7
|
C23H14D7NO2
|
|
3-hexylresorcylic acid
|
2749340-58-5
|
C13H18O4
|
|
JWH 398-d9
|
2749349-31-1
|
C24H13ClD9NO
|
|
Parecoxib Impurity
|
2749361-92-8
|
C17H15NO4S
|
|
JWH 122 N-(5-hydroxypentyl) metabolite-d5
|
2749387-95-7
|
C25H20D5NO2
|
|
AM2201 2-hydroxyindole metabolite
|
2749391-49-7
|
C24H22FNO2
|
|
Riociguat-13C-d3
|
2749393-44-8
|
C20H16D3FN8O2
|